Search Results

There are 125958 results for: content related to: Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts

  1. You have free access to this content
    Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator-activated receptor γ–independent regulation of nucleophosmin

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 493–505, Andrea Galli, Elisabetta Ceni, Tommaso Mello, Simone Polvani, Mirko Tarocchi, Francesca Buccoliero, Francesca Lisi, Laura Cioni, Barbara Ottanelli, Valeria Foresta, Guido Mastrobuoni, Gloriano Moneti, Giuseppe Pieraccini, Calogero Surrenti and Stefano Milani

    Version of Record online : 15 MAR 2010, DOI: 10.1002/hep.23669

  2. Peroxisome proliferator–activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 418–425, Y.-C. YANG, Y.-P. TSAO, T.-C. HO and I.-P CHOUNG

    Version of Record online : 21 FEB 2007, DOI: 10.1111/j.1525-1438.2006.00866.x

  3. You have free access to this content
    Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists

    British Journal of Pharmacology

    Volume 170, Issue 5, November 2013, Pages: 1137–1151, Kenneth K W To and Brian Tomlinson

    Version of Record online : 15 OCT 2013, DOI: 10.1111/bph.12367

  4. You have full text access to this Open Access content
    In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth

    Cancer Science

    Volume 101, Issue 9, September 2010, Pages: 1955–1964, Naohiko Hamaguchi, Hironobu Hamada, Seigo Miyoshi, Kazunori Irifune, Ryoji Ito, Tatsuhiko Miyazaki and Jitsuo Higaki

    Version of Record online : 27 MAY 2010, DOI: 10.1111/j.1349-7006.2010.01632.x

  5. You have free access to this content
    The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology

    Experimental Dermatology

    Volume 24, Issue 4, April 2015, Pages: 245–251, Yuval Ramot, Arianna Mastrofrancesco, Emanuela Camera, Pierre Desreumaux, Ralf Paus and Mauro Picardo

    Version of Record online : 27 MAR 2015, DOI: 10.1111/exd.12647

  6. Hypoadiponectinaemia in diabetes mellitus type 2: molecular mechanisms and clinical significance

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 12, December 2011, Pages: 897–904, Hui Su, Wayne Bond Lau and Xin-Liang Ma

    Version of Record online : 27 NOV 2011, DOI: 10.1111/j.1440-1681.2011.05606.x

  7. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis

    Journal of Cellular Physiology

    Volume 217, Issue 2, November 2008, Pages: 367–376, Andrea V. Leisewitz, Carolina R. Urrutia, Gabriela R. Martinez, Gloria Loyola and Miguel Bronfman

    Version of Record online : 9 JUN 2008, DOI: 10.1002/jcp.21509

  8. PPAR γ activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes

    Journal of Neuroscience Research

    Volume 72, Issue 4, 15 May 2003, Pages: 425–435, Alejandro D. Roth, Andrea V. Leisewitz, Juan E. Jung, Patricia Cassina, Luis Barbeito, Nibaldo C. Inestrosa and Miguel Bronfman

    Version of Record online : 20 MAR 2003, DOI: 10.1002/jnr.10596

  9. You have full text access to this Open Access content
    Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications

    Journal of Diabetes Investigation

    Volume 3, Issue 1, February 2012, Pages: 11–23, Takeshi Matsumura, Kayo Taketa, Seiya Shimoda and Eiichi Araki

    Version of Record online : 1 DEC 2011, DOI: 10.1111/j.2040-1124.2011.00182.x

  10. Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 3, March 2015, Pages: 287–292, Chia-An Chou, Hwee-Yeong Ng, Wei-Hung Kuo, Ting-Yu Terry Chiou, Sung-Nan Pei, Lung-Chih Li, Yueh-Ting Lee and Chien-Te Lee

    Version of Record online : 11 FEB 2015, DOI: 10.1111/1440-1681.12351

  11. Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts

    British Journal of Dermatology

    Volume 163, Issue 3, September 2010, Pages: 650–651, A. Antonelli, C. Ferri, S.M. Ferrari, M. Colaci, D. Giuggioli and P. Fallahi

    Version of Record online : 8 MAY 2010, DOI: 10.1111/j.1365-2133.2010.09844.x

  12. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells

    European Journal of Haematology

    Volume 83, Issue 3, September 2009, Pages: 191–202, Haiwen Huang, Depei Wu, Jinxiang Fu, Guanghua Chen, Weirong Chang, Howard C. H. Chow, Anskar Y. H. Leung and Raymond Liang

    Version of Record online : 8 MAY 2009, DOI: 10.1111/j.1600-0609.2009.01277.x

  13. You have free access to this content
    Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study

    Diabetes/Metabolism Research and Reviews

    Volume 23, Issue 5, July/August 2007, Pages: 392–399, Bernard Chappuis, Monika Braun, Christoph Stettler, Sabine Allemann, Peter Diem, Peter J. Lumb, Anthony S. Wierzbicki, Richard James and Emanuel R. Christ

    Version of Record online : 8 JAN 2007, DOI: 10.1002/dmrr.715

  14. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 6, June 2011, Pages: 358–364, Wei Pang, Nan Li, Ding Ai, Xiao-Lin Niu, You-Fei Guan and Yi Zhu

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1440-1681.2011.05492.x

  15. You have free access to this content
    Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction

    International Journal of Cancer

    Volume 131, Issue 7, 1 October 2012, Pages: E1055–E1066, Ravi P. Sahu, Sonia C. DaSilva, Badri Rashid, Kellie Clay Martel, Danielle Jernigan, Shama R. Mehta, Deena R. Mohamed, Samin Rezania, Joshua R. Bradish, Andrew B. Armstrong, Simon Warren and Raymond L. Konger

    Version of Record online : 18 APR 2012, DOI: 10.1002/ijc.27562

  16. Pleiotropic Role of PPARγ in Intracerebral Hemorrhage: An Intricate System Involving Nrf2, RXR, and NF-κB

    CNS Neuroscience & Therapeutics

    Volume 21, Issue 4, April 2015, Pages: 357–366, Xiu-Rong Zhao, Nicole Gonzales and Jaroslaw Aronowski

    Version of Record online : 28 NOV 2014, DOI: 10.1111/cns.12350

  17. You have free access to this content
    Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells

    Hepatology

    Volume 55, Issue 6, June 2012, Pages: 1942–1953, Komal Ramani and Maria Lauda Tomasi

    Version of Record online : 23 APR 2012, DOI: 10.1002/hep.25594

  18. You have free access to this content
    A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5403–5413, Michael J. Pishvaian, John L. Marshall, Andrew J. Wagner, Jimmy J. Hwang, Shakun Malik, Ion Cotarla, John F. Deeken, A. Ruth He, Hirut Daniel, Abdel-Baset Halim, Hamim Zahir, Catherine Copigneaux, Kejian Liu, Robert A. Beckman and George D. Demetri

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27526

  19. You have free access to this content
    Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation

    British Journal of Pharmacology

    Volume 168, Issue 1, January 2013, Pages: 266–275, S Fogli, F Stefanelli, L Picchianti, M Del Re, V Mey, C Bardelli, R Danesi and MC Breschi

    Version of Record online : 18 DEC 2012, DOI: 10.1111/j.1476-5381.2012.02180.x

  20. Targeting soluble epoxide hydrolase via peroxisome proliferator-activated receptor γ: A new therapeutic strategy for vascular complications

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 6, June 2011, Pages: 356–357, Siu Ling Wong and Yu Huang

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1440-1681.2011.05507.x